SCHEMBL7304794

SCHEMBL7304794

COc1ccc(SC(CC(=O)O)CC2CCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.43
MMP1 P03956 3/20 0.41
MMP2 P08253 3/20 0.41
MMP3 P08254 3/20 0.41
FFAR1 O14842 2/20 0.40
CTSK P43235 1/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
POLB P06746 1/20 0.39
KLK7 P49862 2/20 0.39
ALDH1A1 P00352 3/20 0.38
CTSS P25774 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CHRM2 P08172 1/20 0.38
CASP1 P29466 1/20 0.38
CASP3 P42574 1/20 0.38
CASP8 Q14790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308194 0.86 MMP3 (0.53) EPHX2MMP1MMP2MMP3CTSK
SCHEMBL7310255 0.83 EPHX2 (0.43) EPHX2MMP1MMP2MMP3CTSK
SCHEMBL7302605 0.77 ALDH1A1 (0.41) EPHX2CTSKKMT2APOLBKLK7
SCHEMBL6823946 0.75 PPARG (0.52) MMP1MMP2MMP3KMT2ANPC1
SCHEMBL12264121 0.73 KMT2A (0.47) MMP2FFAR1KMT2AATMALDH1A1
SCHEMBL7067078 0.73 MMP9 (0.46) MMP1MMP2MMP3
SCHEMBL7307517 0.72 ADAM17 (0.43) EPHX2MMP1MMP2MMP3CTSK
SCHEMBL2646192 0.71 EPHX2 (0.48) EPHX2POLBKLK7ALDH1A1
SCHEMBL6823537 0.71 MMP1 (0.49) MMP1MMP2MMP3KMT2AATM
SCHEMBL6823578 0.71 MMP12 (0.48) MMP2FFAR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed